KANGSTEM BIOTECH CO., LTD.

Highlights Kangstem Biotech Co., Ltd.

Equities

A217730

KR7217730001

End-of-day quote Korea S.E. Other stock markets 03:30:00 05/06/2024 am IST			5-day change	1st Jan Change
2,745 ^KRW	-7.11%		-8.96%	+14.61%

09/05	HLB bioStep Co.,Ltd. announced that it has received KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.	CI
25/04	An undisclosed buyer agreed to acquire a 24.27% stake in Croen Inc. from Kangstem Biotech Co., Ltd. for KRW 2.8 billion	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

An undisclosed buyer agreed to acquire a 24.27% stake in Croen Inc. from Kangstem Biotech Co., Ltd. for KRW 2.8 billion	25/04	CI
Kangstem Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
Kang Stem Biotech Co., Ltd. cancelled the acquisition of 60% stake in Croen Inc.	20/18/20	CI
Kang Stem Biotech Co., Ltd. agreed to acquire a 60% stake in Croen Inc. for KRW 2.7 billion.	20/17/20	CI
ORIG3N, Inc and Kangstem Biotech Announce Collaboration to Study Neural Stem Cells	21/16/21	CI
Lutronic Corporation cancelled the sale of 4.11% stake in Kang Stem Biotech Co., Ltd.	07/16/07	CI
Kang Stem Biotech Co., Ltd. has completed an IPO in the amount of KRW 12.00 billion.	16/15/16	CI
Kang Stem Biotech Co., Ltd. has filed an IPO in the amount of KRW 20.00 billion.	22/15/22	CI
Lutronic Corporation signed a contract to sell 4.11% stake in Kang Stem Biotech Co., Ltd. for KRW 2.4 billion.	08/15/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer